These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 31337258

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling.
    Holanda VAD, de Almeida RN, de Oliveira MC, da Silva Junior ED, Galvão-Coelho NL, Calo' G, Ruzza C, Gavioli EC.
    Psychopharmacology (Berl); 2024 May; 241(5):1001-1010. PubMed ID: 38270614
    [Abstract] [Full Text] [Related]

  • 6. Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness.
    Holanda VA, Medeiros IU, Asth L, Guerrini R, Calo' G, Gavioli EC.
    Psychopharmacology (Berl); 2016 Jul; 233(13):2525-32. PubMed ID: 27129865
    [Abstract] [Full Text] [Related]

  • 7. Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
    Silva EF, Silva AI, Asth L, Souza LS, Zaveri NT, Guerrini R, Calo' G, Ruzza C, Gavioli EC.
    Behav Brain Res; 2019 Jan 01; 356():120-126. PubMed ID: 30142397
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure.
    Taylor RM, Jeong IH, May MD, Bergman EM, Capaldi VF, Moore NLT, Matson LM, Lowery-Gionta EG.
    Psychopharmacology (Berl); 2020 Oct 01; 237(10):2943-2958. PubMed ID: 32588078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
    Goeldner C, Spooren W, Wichmann J, Prinssen EP.
    Psychopharmacology (Berl); 2012 Jul 01; 222(2):203-14. PubMed ID: 22249359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
    Thomas RC, Bath MF, Stover CM, Lambert DG, Thompson JP.
    Peptides; 2014 Nov 01; 61():56-60. PubMed ID: 25161013
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus.
    D'Oliveira da Silva F, Azevedo Neto J, Sturaro C, Guarino A, Robert C, Gavioli EC, Calo G, Mouledous L, Ruzza C.
    Neuropharmacology; 2022 Jul 01; 212():109077. PubMed ID: 35513173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.